Niox Group PLC (NIOX)

ORD 0.08P

Sell: 69.60p|Buy: 70.40p|Change: 0.40 (-0.57%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Company profile

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the UnitedStates, the United Kingdom, and the Rest of the world.

Address

Magdalen Centre, Robert Robinson Avenue
Northbrook House, Oxford Science Park
Oxford
GBR
OX4 4GA

Telephone

+44 1865405560

Website

https://www.niox.com

Sector

Healthcare

Forecast key dates

Name	Key Date
NIOX Group PLC Second Quarter Earnings Results for 2026	2026-09-30T00:00:00
NIOX Group PLC Annual General Meeting for 2026	2026-05-14T11:00:00
NIOX Group PLC Fourth Quarter Earnings Results for 2025	2026-04-01T00:00:00
NIOX Group PLC Annual Report for 2025	2026-04-01T00:00:00

Previous key dates

Name	Key Date
NIOX Group PLC Second Quarter Earnings Results for 2025	2025-09-30T00:00:00
NIOX Group PLC Annual General Meeting for 2025	2025-05-14T11:00:00
NIOX Group PLC Fourth Quarter Earnings Results for 2024	2025-04-01T00:00:00
NIOX Group PLC Annual Report for 2024	2025-04-01T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.